Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2502 USD | +1.30% | -4.50% | -88.20% |
Mar. 28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 14-12-31 | |
Irina Pestrikova
DFI | Director of Finance/CFO | 38 | 21-06-17 |
Michael Thornton
CTO | Chief Tech/Sci/R&D Officer | 55 | 06-12-31 |
Steve Freeman
HRO | Human Resources Officer | - | 17-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 13-06-30 | |
Alexander Tokman
BRD | Director/Board Member | 62 | 07-12-31 |
Michael Harsh
BRD | Director/Board Member | 69 | 14-12-31 |
Louis Basenese
BRD | Director/Board Member | 46 | 20-04-08 |
Chief Executive Officer | 58 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,035,659 | 10,687,672 ( 96.85 %) | 0 | 96.85 % |
Stock B | 0 | 141,397 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.20% | 2.76M | |
-0.02% | 42.11B | |
+48.43% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- NDRA Stock
- Company ENDRA Life Sciences Inc.